Skip to main content
OpenTrials
Completed

NCT Number: NCT03188588

Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients

Long-term oxygen therapy (LTOT) is the reference treatment for chronic respiratory failure. This treatment is based on the principle of oxygen supplementation via a source to correct hypoxemia in patients. At present, adherence to this treatment is difficult to evaluate (reporting by patients), but the results of the literature show poor LTOT compliance. It is therefore important to accurately measure the oxygen consumption by patients and to understand the factors explaining LTOT compliance. The ultimate aim is to improve our patient management to make them more observant in order to improve the therapeutic efficacy of the treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Respiratory Disease Hypoxemia Hypoxia Pathological Conditions, Signs and Symptoms Signs and Symptoms Signs and Symptoms, Respiratory

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Arnaud de Villeneuve

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • chronic respiratory disease patients with chronic hypoxemia
  • First prescribed long term oxygenotherapy

Exclusion criteria

  • patients with NIV and CPAP
  • vital pronostic < 3 months

Treatment and study plan

Primary outcomes

  1. oxygen use

    Time frame: 6 month

    time of oxygen use

Secondary outcomes

  1. respiratory disease severity based on GOLD standards

    Time frame: baseline

  2. quality of life assessed by a questionnaire (VQ-11)

    Time frame: baseline, 3 month and 6 month

  3. precarity score assessed by a questionnaire (EPICE)

    Time frame: baseline

Sponsors and collaborators

Lead sponsor

SOS Oxygene Mediterranee

Industry

Collaborators

  • CHU Arnaud de Villeneuve MONTPELLIER

Registry information

Acronym: ObsO2

Important dates

Study start
2017
Primary completion
2019
Study completion
2020
First posted
Jun 15, 2017
Registry last updated
Sep 23, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.